Circulation Research, Vol 58, 839-845, Copyright © 1986 by American Heart Association
ARTICLES |
AW Clowes and MM Clowes
Heparin inhibits the development of intimal thickening after carotid injury in the rat; however, the specific cellular events responsible for this effect have not been defined. In this study, smooth muscle cell growth fraction and migration into the intima were quantitatively measured in heparin-treated animals. All rats were subjected to left carotid balloon injury and received continuous intraperitoneal infusion of tritiated thymidine; they were given either heparin or lactated Ringer's solution intravenously for periods of time up to 7 days. Both smooth muscle cell growth fraction and migration of nondividing smooth muscle cells were markedly reduced in heparin-treated rats. If heparin was administered for only the first 3 days after carotid injury, both smooth muscle growth fraction and migration were reduced at 7 days; on the other hand, heparin had no effect on growth fraction and migration if given from day 4 to day 7. Finally, heparin given for a period of 1 week produced marked reduction in smooth muscle cell accumulation in injured arteries at 2 and 4 weeks. These results suggest that the effect of heparin on injury-induced intimal thickening might be due to inhibition of both smooth muscle cell entry into the growth fraction and migration of medial smooth muscle cells into the intima. These effects are long lasting, and are not reversed even if heparin is stopped after a short course of administration.
This article has been cited by other articles:
![]() |
N. Fukai, R. D. Kenagy, L. Chen, L. Gao, G. Daum, and A. W. Clowes Syndecan-1: An Inhibitor of Arterial Smooth Muscle Cell Growth and Intimal Hyperplasia Arterioscler Thromb Vasc Biol, September 1, 2009; 29(9): 1356 - 1362. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. R. Mason, R. A. Nowak, C. C. Morton, and J. J. Castellot Jr. Heparin Inhibits the Motility and Proliferation of Human Myometrial and Leiomyoma Smooth Muscle Cells Am. J. Pathol., June 1, 2003; 162(6): 1895 - 1904. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Rolfe, S. Stamatiou, C. J. World, L. Brown, A. C. Thomas, J. A. Bingley, N. F. Worth, and J. H. Campbell Leukaemia inhibitory factor retards the progression of atherosclerosis Cardiovasc Res, April 1, 2003; 58(1): 222 - 230. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G.P. Welt and C. Rogers Inflammation and Restenosis in the Stent Era Arterioscler Thromb Vasc Biol, November 1, 2002; 22(11): 1769 - 1776. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Liu, M. Fisher, and P. Groves Down-regulation of the ERK1 and ERK2 mitogen-activated protein kinases using antisense oligonucleotides inhibits intimal hyperplasia in a porcine model of coronary balloon angioplasty Cardiovasc Res, June 1, 2002; 54(3): 640 - 648. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Paramo, H. Sendzischew, and M. Sivina Comparison of the Use of Enoxaparin Versus Unfractionated Heparin in Patients Undergoing Lower Extremity Revascularization Vascular and Endovascular Surgery, May 1, 2002; 36(3): 199 - 205. [Abstract] [PDF] |
||||
![]() |
P.J. de Feyter The quest for the ideal stent Eur. Heart J., October 1, 2001; 22(19): 1766 - 1768. [PDF] |
||||
![]() |
J Wohrle, E Al-Khayer, U Grotzinger, C Schindler, M Kochs, V Hombach, and M Hoher Comparison of the heparin coated vs the uncoated Jostent(R)--no influence on restenosis or clinical outcome Eur. Heart J., October 1, 2001; 22(19): 1808 - 1816. [Abstract] [PDF] |
||||
![]() |
F. G. P. Welt, E. R. Edelman, D. I. Simon, and C. Rogers Neutrophil, Not Macrophage, Infiltration Precedes Neointimal Thickening in Balloon-Injured Arteries Arterioscler Thromb Vasc Biol, December 1, 2000; 20(12): 2553 - 2558. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Meneveau, F Schiele, G Grollier, B Farah, J.M Lablanche, K Khalife, J Machecourt, N Danchin, J.E Wolf, M Simpson, et al. Local delivery of nadroparin for the prevention of neointimal hyperplasia following stent implantation: results of the IMPRESS Trial. A multicentre, randomized, clinical, angiographic and intravascular ultrasound study Eur. Heart J., November 1, 2000; 21(21): 1767 - 1775. [Abstract] [PDF] |
||||
![]() |
M. A. Lovich and E. R. Edelman Tissue concentration of heparin, not administered dose, correlates with the biological response of injured arteries in vivo PNAS, September 28, 1999; 96(20): 11111 - 11116. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ikari, B. M. McManus, J. Kenyon, and S. M. Schwartz Neonatal Intima Formation in the Human Coronary Artery Arterioscler Thromb Vasc Biol, September 1, 1999; 19(9): 2036 - 2040. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sawada, H. Yanamoto, I. Nagata, N. Hashimoto, I. Nakahara, Y. Akiyama, H. Kikuchi, and R. L. Macdonald Prevention of Neointimal Formation by a Serine Protease Inhibitor, FUT-175, After Carotid Balloon Injury in Rats • Editorial Comment Stroke, March 1, 1999; 30(3): 644 - 650. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Hart, L. W. Kraiss, S. Vergel, D. Gilbertson, R. Kenagy, T. Kirkman, D. L. Crandall, S. Tickle, H. Finney, G. Yarranton, et al. PDGFß Receptor Blockade Inhibits Intimal Hyperplasia in the Baboon Circulation, February 2, 1999; 99(4): 564 - 569. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C Newby and A. B Zaltsman Fibrous cap formation or destruction -- the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation Cardiovasc Res, February 1, 1999; 41(2): 345 - 360. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Heckenkamp and G. M. Lamuraglia Intimal Hyperplasia, Arterial Remodeling, and Restenosis: An Overview Perspectives in Vascular Surgery and Endovascular Therapy, January 1, 1999; 11(2): 71 - 94. [Abstract] [PDF] |
||||
![]() |
K. OKADA, M. L. BERNSTEIN, W. ZHANG, D. P. SCHUSTER, and M. D. BOTNEY Angiotensin-converting Enzyme Inhibition Delays Pulmonary Vascular Neointimal Formation Am. J. Respir. Crit. Care Med., September 1, 1998; 158(3): 939 - 950. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chaux, X. M. Ruan, M. C. Fishbein, Y. Ouyang, S. Kaul, J. A. Pass, and J. M. Matloff Perivascular Delivery Of A Nitric Oxide Donor Inhibits Neointimal Hyperplasia In Vein Grafts Implanted In The Arterial Circulation J. Thorac. Cardiovasc. Surg., March 1, 1998; 115(3): 604 - 614. [Abstract] [Full Text] |
||||
![]() |
C. Lundgren, B. Vinogradsky, A. Guala, and S. Fujii A Vitronectin Receptor Antagonist Inhibits Neointimal Formation After Balloon Arterial Injury in Rabbits in Vivo Vascular and Endovascular Surgery, January 1, 1998; 32(1): 47 - 53. [Abstract] [PDF] |
||||
![]() |
H. Yasukawa, T. Imaizumi, H. Matsuoka, A. Nakashima, and M. Morimatsu Inhibition of Intimal Hyperplasia After Balloon Injury by Antibodies to Intercellular Adhesion Molecule-1 and Lymphocyte Function–Associated Antigen-1 Circulation, March 18, 1997; 95(6): 1515 - 1522. [Abstract] [Full Text] |
||||
![]() |
A. Nagler, H.-Q. Miao, H. Aingorn, M. Pines, O. Genina, and I. Vlodavsky Inhibition of Collagen Synthesis, Smooth Muscle Cell Proliferation, and Injury-Induced Intimal Hyperplasia by Halofuginone Arterioscler Thromb Vasc Biol, January 1, 1997; 17(1): 194 - 202. [Abstract] [Full Text] |
||||
![]() |
R. Forough, N. Koyama, D. Hasenstab, H. Lea, M. Clowes, S. T. Nikkari, and A. W. Clowes Overexpression of Tissue Inhibitor of Matrix Metalloproteinase-1 Inhibits Vascular Smooth Muscle Cell Functions In Vitro and In Vivo Circ. Res., October 1, 1996; 79(4): 812 - 820. [Abstract] [Full Text] |
||||
![]() |
M. Janiszewski, F. R. M. Laurindo, C. A. Pasqualucci, P. L. da Luz, and F. Pileggi Effects of a Single Heparin Bolus on Neointimal Growth After Arterial Injury in Intact Rabbits Angiology, June 1, 1996; 47(6): 549 - 556. [Abstract] [PDF] |
||||
![]() |
M.-L. Bochaton-Piallat, P. Ropraz, F. Gabbiani, and G. Gabbiani Phenotypic Heterogeneity of Rat Arterial Smooth Muscle Cell Clones : Implications for the Development of Experimental Intimal Thickening Arterioscler Thromb Vasc Biol, June 1, 1996; 16(6): 815 - 820. [Abstract] [Full Text] |
||||
![]() |
R. Sarkar, E. G. Meinberg, J. C. Stanley, D. Gordon, and R. Clinton Webb Nitric Oxide Reversibly Inhibits the Migration of Cultured Vascular Smooth Muscle Cells Circ. Res., February 1, 1996; 78(2): 225 - 230. [Abstract] [Full Text] |
||||
![]() |
J. Sang Park, Seung Nam Kim, Jong Man Won, Yong Bok Koh, and In Chul Kim Synergistic Inhibitory Effect of Angiotensin-Converting Enzyme Inhibitor and Heparin on Intimal Hyperplasia After Rat Aorta Injury Angiology, January 1, 1996; 47(1): 9 - 14. [Abstract] [PDF] |
||||
![]() |
R. L. Geary, N. Koyama, T. W. Wang, S. Vergel, and A. W. Clowes Failure of Heparin to Inhibit Intimal Hyperplasia in Injured Baboon Arteries : The Role of Heparin-Sensitive and -Insensitive Pathways in the Stimulation of Smooth Muscle Cell Migration and Proliferation Circulation, June 15, 1995; 91(12): 2972 - 2981. [Abstract] [Full Text] |
||||
![]() |
M. Rabinovitch Investigational Approaches to Pulmonary Hypertension*1,2 Toxicol Pathol, January 1, 1991; 19(4-1): 458 - 469. [Abstract] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1986 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |